The Promise of Genome Editing with Caribou Biosciences' Rachel Haurwitz, Ph.D.

<p>On this episode of Cell &amp; Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou&apos;s chRDNA genome editing technology and how it differs from CRISPR-Cas9.</p>